The combination of technology and the medical sector helps to improve patient therapies and outcomes. The movement towards a home-based environment in drug delivery helps enhance patient welfare and well-being.
FREMONT, CA: Many trends in the medical technology field revolve around enhancing regulatory requirements. However, the market focus on moving towards more personalized medicine such as the cell and gene therapies, the total cost of health is a driving factor, while most of the patient population indication comprises diabetes and rheumatoid arthritis. The people who have Alzheimer's or Parkinson's still need a breakthrough drug. Presently the pipeline consists of smaller patient population molecules or orphan drugs, which means that the treatments are costly.
Yet another trend that we witness is the combination of technology and healthcare. The tech giants, like Google, partner with pharmaceutical manufacturers to assist in the diagnosis and understanding of biomarkers, and enable patients to access data more efficiently. As the medical technology market moves forward, the industry expects to see an increase in the use of mobile devices and apps to capture data that may help to enhance the health of the population and capture trends for education, care, adherence to treatments, and drug delivery.
What is the movement toward a home-based administration of medicine?
The importance of the need for better patient experience drives the upcoming trends toward a home-based administration. Home-based self-administration helps give the patients their lives back. In terms of delivery systems, the trend toward self-administration requires innovation around devices to make sure that they have the ability to deliver a large dose.
Challenges and opportunities for drug-delivery and combination products in the coming years
The challenges become the opportunities for innovative advancement in the drug delivery platform when considering combination products. The challenges are related directly to the regulatory changes, and some are also related to the delivery approach. Each of these challenges needs a different strategy. As a part of this, the companies have to develop these strategies to meet the guidelines for combination products. The combination of products helps to design solutions for better patient care outcomes by the use of human factors testing.
Both the drug, as well as the device, should have the patient in mind. Developing them together over the drug's lifecycle helps increase the patient experience at the end. Knowing and providing the appropriate dose with the right amount of safety and convenience and easy delivery of the dose will surely help improve the patient's well-being.